Features

TTBD Innovator Spotlight: Xiangshu Xiao, PhD

Xiangshu Xiao, Ph.D., associate professor of physiology and pharmacology in OHSU’s School of Medicine, has been at the forefront in the field of cancer chemical biology. The goal of his research is to develop novel cancer therapeutics, using a combination of chemistry and biology, to create new compounds that target deregulated proteins in cancer cells. In his two main cancer-related projects, Dr. Xiao has developed first-in-class compounds that show significant anti-cancer effects in various preclinical … Read More

Study identifies common grant review criteria across federal agencies

In the current funding environment, it’s essential that investigators diversify their funding portfolios across multiple sources including federal agencies, foundations, and corporations. This presents challenges for applicants who may be overwhelmed by trying to understand various sets of requirements from different funders. In an effort to help researchers navigate this terrain and lower the barrier for diversification, two research development (professionals? researchers?), Holly J. Falk-Krezensinski, Ph.D, and Stacey C. Tobin, Ph.D., examined the review criteria of … Read More

OTRADI launches interactive bioscience ecosystem map

The Oregon Translational Research and Development Institute (OTRADI) has launched the first interactive Oregon Bioscience Ecosystem and Map. The comprehensive database and searchable map showcases the breadth and diversity of Oregon’s thriving bioscience industry. The interactive map allows visitors to search bioscience companies by area of focus, company size, and location. It is intended to capture the broader bioscience ecosystem by highlighting the state’s incubators, accelerators, investors, research institutions, contract research and manufacturing organizations, in addition to relevant … Read More

White House to request $1 billion for cancer research

President Obama is seeking $755 million in cancer research funding as part of his 2017 budget. Congress has already approved $195 million in research funding in 2016, which would bring total funding to nearly $1 billion over the next two years. These funds are meant to jump-start ongoing research as part of the Administration’s “moonshot” goal of curing cancer. A task force led by Vice President Biden and including representatives from the NIH, DHHS, DoD, FDA, … Read More

Update on NIH policy and guideline changes

As we reported in October, several changes to NIH policies, forms, and instructions go into effect for applications submitted on Monday, Jan. 25, and beyond (Phase I of the change rollout).  Additional changes apply to applications submitted on or after May 25 (Phase II), while several modifications scheduled for Phase II have been pushed back to fiscal year 2017 (those related to rigor and transparency for career development awards). Because the changes are many and nuanced, … Read More

TTBD Startup Spotlight: Gobiquity Mobile Health, Inc.

Of the 25 million children between the ages of six months and six years old, more than 15 percent show risk factors for amblyopia, the leading cause of visual impairment in children. In addition, only 20 percent of children receive proper vision screenings. Gobiquity Mobile Health, Inc., an OHSU startup company founded in 2010, specializes in prescribed mobile health diagnostics. Gobiquity is on a mission to end amblyopia through early screening and diagnosis. Its flagship … Read More

Demolition of Vollum south side facade scheduled Jan. 18 – Feb. 29

The demolition of the south facade of the Vollum Institute began Monday, Jan. 18, and will continue through Friday, Feb. 29. Work will take place during weekdays after 3:30 p.m. to minimize impacts. The project will replace the aging terracotta facade of the Vollum, and includes: Installation of covered scaffolding for access and protection from falling debris Removal of all existing terracotta on the Vollum facade Installation of a new weather barrier Replacement of all … Read More

Researchers discuss out-of-hospital births in NEJM online forum starting Jan. 6

The NEJM Group Open Forum, a live, online discussion intended to generate conversation around important (and sometimes controversial) ideas, will feature a trio of OHSU researchers for the next 10 days. Jonathan Snowden, Ph.D., Aaron Caughey, M.D., Ph.D., and Ellen Tilden, Ph.D., C.N.M., whose article about out-of-hospital births and birth outcomes is at the center of the current forum, will each log in daily to respond to comments and questions asked by the online community. See what others are saying … Read More

TTBD Industry Spotlight: CORI software and Due North Innovation

Of the millions of colonoscopies and endoscopic procedures performed in the U.S., there is very little information on the cause and result of the procedures once they are performed. To figure out which patient is likely to experience side effects from the procedure, David Lieberman, M.D., head of OHSU’s Division of Gastroenterology, led the initiative in 1994 to create a national endoscopic database repository to learn more about patients receiving gastrointestinal procedures. With help from … Read More

Cardiac arrest drug study complete, patients no longer need to opt out from the ALPS study

In 2012, OHSU joined other health centers across North America in a clinical trial to determine whether two drugs commonly used to stabilize the heart during cardiac arrest actually improve survival rates and neurological function among cardiac arrest victims. The study was completed last month, with results expected in spring 2016. OHSU researchers conducting the study hereby notify the public of the study’s completion, which used a unique methodology. Because patients eligible for this study … Read More

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at Oregon Health & Science University. Visit often for updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.

Categories

Archives